Collaboration, License and Option Agreements - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended		36 Months Ended
	Nov. 18, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2021	Dec. 31, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date						2019-04
Liability to licensor		$ 19,806		$ 19,806			$ 19,806
BeiGene
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date						2021-11
Upfront Non-Refundable Payment						$ 25,000
Revenues		0	$ 0	0	$ 0
Current portion of deferred revenue	$ 19,800
License termination information, Description	In the event the license is terminated, the liability will be extinguished with no further payment to BeiGene.
Liability to licensor		19,800		19,800			$ 19,800
Context Therapeutics Inc
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Revenues		11,000		11,000
Maximum Potential Aggregate Payments		$ 133,500		$ 133,500